128 related articles for article (PubMed ID: 38841458)
1. HRCT findings predict 1-year mortality in patients with acute exacerbation of idiopathic inflammatory myopathies-associated interstitial lung disease.
Zhang J; He L; Han T; Tong J; Ren J; Pu J; Zhang M; Guo Y; Jin C
Heliyon; 2024 Jun; 10(11):e31510. PubMed ID: 38841458
[TBL] [Abstract][Full Text] [Related]
2. Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model.
Cao H; Huan C; Wang Q; Xu G; Lin J; Zhou J
Rheumatol Ther; 2020 Dec; 7(4):967-978. PubMed ID: 33106937
[TBL] [Abstract][Full Text] [Related]
3. Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study.
Liang J; Cao H; Ke Y; Sun C; Chen W; Lin J
Front Med (Lausanne); 2020; 7():12. PubMed ID: 32083087
[No Abstract] [Full Text] [Related]
4. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria.
Yamakawa H; Sato S; Tsumiyama E; Nishizawa T; Kawabe R; Oba T; Kamikawa T; Horikoshi M; Akasaka K; Amano M; Kuwano K; Matsushima H
J Thorac Dis; 2019 Dec; 11(12):5247-5257. PubMed ID: 32030242
[TBL] [Abstract][Full Text] [Related]
6. Fever in the initial stage of IIM patients: an early clinical warning sign for AE-ILD.
Liu T; Chen H; Shi Y; Xu W; Yuan F
Adv Rheumatol; 2023 Jul; 63(1):31. PubMed ID: 37443073
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of tacrolimus on top of glucocorticoids in the management of IIM-ILD: A retrospective and prospective study.
Chen Y; Bai Z; Zhang Z; Hu Q; Zhong J; Dong L
Front Immunol; 2022; 13():978429. PubMed ID: 36119045
[TBL] [Abstract][Full Text] [Related]
9. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases.
Nurmi HM; Elfving PK; Kettunen HP; Suoranta SK; Järvinen HMI; Kuittinen VAE; Purokivi MK; Kaarteenaho RL; Koskela HO
J Thorac Dis; 2023 Feb; 15(2):311-322. PubMed ID: 36910053
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review.
Ge Y; Peng Q; Zhang S; Zhou H; Lu X; Wang G
Clin Rheumatol; 2015 Jan; 34(1):99-105. PubMed ID: 25367345
[TBL] [Abstract][Full Text] [Related]
13. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
[TBL] [Abstract][Full Text] [Related]
15. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
[TBL] [Abstract][Full Text] [Related]
16. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study.
Hozumi H; Nakamura Y; Johkoh T; Sumikawa H; Colby TV; Kono M; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Suda T; Chida K
BMJ Open; 2013 Sep; 3(9):e003132. PubMed ID: 24038004
[TBL] [Abstract][Full Text] [Related]
17. FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study.
Kastrati K; Nakuz TS; Kulterer OC; Geßl I; Simader E; Mrak D; Bonelli M; Kiener HP; Prayer F; Prosch H; Aletaha D; Langsteger W; Traub-Weidinger T; Blüml S; Lechner-Radner H; Hacker M; Mandl P
EClinicalMedicine; 2024 Jun; 72():102598. PubMed ID: 38633577
[TBL] [Abstract][Full Text] [Related]
18. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease.
Hannah JR; Law HE; Gordon T; Rooney M; Buazon A; Adas M; Nagra D; Stovin C; Galloway J; Gordon PA
J Rheumatol; 2023 Mar; 50(3):373-383. PubMed ID: 36379584
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]